Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-labeled, non-comparative study to examine the safety and
efficacy of ASP1585 for long-term dosing in chronic kidney disease patients with
hyperphosphatemia not on dialysis.